Unbiased and Practical Psychopharmacology Updates

Get exclusive psychopharmacology updates. Earn up to 155 CMEs, including 40 SA CMEs credits.

Explore Memberships

Receive psychopharmacology updates in your inbox

TRENDING IN PSYCHOPHARMACOLOGY INSTITUTE

Quick Takes

Five research summaries in adult psychiatry, each month. CME available for Silver and Gold members.

“Cade’s Disease” and Beyond: Misdiagnosis, Antidepressant Use, and a Proposed Definition for Bipolar Spectrum Disorder

Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis

Effect of Anxiolytic Drug Silexan on Sleep – A Narrative Review

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

Intermittent Selective Serotonin Reuptake Inhibitors for Premenstrual Syndromes: A Systematic Review and Meta-Analysis of Randomized Trials

View All

Expert Consultations

We interview experts who share clinical pearls for your busy practice. CME available for Silver and Gold members.

Pharmacotherapies for Stimulant Use Disorder – Interview

Pharmacologic Management of BPD: Recent Developments-Interview

Antipsychotic Switching: Intersection of Art and Science – Interview

Management of Behavioral and Psychological Symptoms of Dementia – Interview

OCD in Children and Adolescents – Interview

View All

Video Lectures

A selection of practical sections from our video lectures. CME available for Bronze, Silver, and Gold members.

Initiating and Optimizing Clozapine

Treating Anxiety Disorders in Patients With Cancer

Prevalence, Assessment, and Management of RBD

Considerations for Using Benzodiazepines and Benzodiazepine Receptor Agonists in the Geriatric Population

Use of Omega-3 Fatty Acids in Children and Adolescents

View All

RECENT PUBLICATIONS

Trazodone Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

0.50 CMEs
This guide provides a comprehensive review of trazodone, a serotonin antagonist and reuptake inhibitor (SARI) FDA-approved for depression but predominantly prescribed off-label for insomnia, covering its dose-dependent pharmacology, clinical uses, drug interactions, side effects including priapism and QT prolongation, and special population considerations.
Sebastián Malleza, M.D.
Psychopharmacology Institute
View more info

Lithium: How to Manage Dosage and Side Effects – Interview

0.75 CMEs
A discussion on lithium dosing and side effect management in bipolar disorder, covering therapeutic levels, renal protection strategies, weight gain mechanisms, nephrogenic diabetes insipidus, cognitive effects, tremor differentiation, and dermatologic complications with practical solutions for clinical challenges.
David Osser, M.D.
Harvard Medical School
40.01 minutes of audio interview

Pharmacotherapy Bipolar Depression: Strategies for Everyday Management

1.75 CMEs
A comprehensive series on bipolar depression covering subtypes, assessment tools, and evidence-based treatments. Topics include lithium, lamotrigine, atypical antipsychotics, and off-label options like pramipexole and light therapy.
Chris Aiken, M.D.
Carlat Psychiatry Report
104.15 minutes in 12 sections

Quick Take Vol. 82

0.50 CMEs
What are the six key tips for switching oral antipsychotics? Does deprescribing antipsychotics after delirium improve outcomes in older adults? Why is xylazine overdose difficult to treat? What does the PAX-D study reveal about pramipexole for depression? Do bioequivalent medications always produce equivalent clinical results?
Faculty: Oliver Freudenreich, M.D., Scott R. Beach, M.D., David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M., Paul Zarkowski, M.D., Derick E. Vergne, M.D.
36.44 minutes in 5 audio sections

2025 in Review: FDA Approvals, Practice Guidelines, and Label Changes in Psychiatry

0.50 CMEs
This guide provides a comprehensive overview of 2025’s key regulatory and guideline updates in psychiatry, covering new FDA approvals, label changes, and practice guidelines across depression, schizophrenia, addiction, neurocognitive disorders, and neurodevelopmental conditions, emphasizing practical implementation considerations for clinicians.
Sebastián Malleza, M.D.
Psychopharmacology Institute
View more info

Pharmacotherapy of Eating Disorders: An Update – Interview

0.50 CMEs
A discussion on pharmacological approaches to eating disorders, covering medication selection and management strategies for anorexia nervosa, bulimia nervosa, and binge eating disorder. Key topics include olanzapine for weight restoration, fluoxetine for bulimia, lisdexamfetamine and topiramate considerations.
Scott Crow, M.D.
University of Minnesota
28.3 minutes of audio interview

Explore our library of over 480 video lectures, podcasts, research summaries, and expert interviews.

Explore Our Library

CME Information

Physicians – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.

This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Download Accreditation Information (PDF)

Nursing professionals – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.

This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The ANCC accepts AMA PRA Category 1 Credit(s)™ as Contact Hours, under this calculation: 1 CME = 1 Contact Hour. 

Download Accreditation Information (PDF)

Physician assistants – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.

This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Download Accreditation Information (PDF)

Self Assessment for MOC – Accreditation Statement
  • Psychopharmacology Institute Self-Assessment Program 2025

Dates: April 1, 2025 – April 1, 2028

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2025 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment, 2023- Part 1

Dates: January 1, 2023 – January 1, 2026

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment, 2023- Part 1 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment Program 2024

Dates: April 1, 2024 – April 1, 2027

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2024 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

Lost as a newly-matched psychiatry resident?

Access ALL our products FREE for 3 months!

Get Instant Access